Neuberger Berman Group LLC Sells 3,970 Shares of Plexus Corp. $PLXS

Neuberger Berman Group LLC decreased its position in Plexus Corp. (NASDAQ:PLXS) by 66.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,014 shares of the technology company’s stock after selling 3,970 shares during the quarter. Neuberger Berman Group LLC’s holdings in Plexus were worth $291,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of PLXS. Kennondale Capital Management LLC grew its position in Plexus by 42.6% during the third quarter. Kennondale Capital Management LLC now owns 6,282 shares of the technology company’s stock valued at $909,000 after acquiring an additional 1,878 shares during the last quarter. Royce & Associates LP raised its stake in shares of Plexus by 32.1% during the third quarter. Royce & Associates LP now owns 12,157 shares of the technology company’s stock worth $1,759,000 after acquiring an additional 2,953 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after acquiring an additional 338,119 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Plexus by 48.3% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 851 shares of the technology company’s stock worth $123,000 after acquiring an additional 277 shares during the last quarter. Finally, Hillsdale Investment Management Inc. boosted its stake in shares of Plexus by 14.7% in the 3rd quarter. Hillsdale Investment Management Inc. now owns 49,925 shares of the technology company’s stock valued at $7,224,000 after purchasing an additional 6,400 shares in the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Insider Buying and Selling

In related news, CEO Todd P. Kelsey sold 5,231 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $195.78, for a total value of $1,024,125.18. Following the sale, the chief executive officer directly owned 83,291 shares of the company’s stock, valued at $16,306,711.98. This trade represents a 5.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Karen Marie Rapp sold 500 shares of the business’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $195.59, for a total value of $97,795.00. Following the transaction, the director owned 8,535 shares in the company, valued at approximately $1,669,360.65. This represents a 5.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 47,995 shares of company stock valued at $9,718,476 over the last ninety days. Corporate insiders own 1.78% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Benchmark increased their target price on shares of Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Stifel Nicolaus boosted their price target on shares of Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research note on Friday, January 30th. Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research report on Sunday. Weiss Ratings raised Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday. Finally, Williams Trading set a $195.00 price objective on Plexus in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $189.20.

Plexus Trading Down 2.8%

NASDAQ:PLXS opened at $185.90 on Monday. The firm has a market capitalization of $4.98 billion, a P/E ratio of 28.91 and a beta of 0.81. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The company has a fifty day moving average of $183.99 and a 200 day moving average of $158.22. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $211.84.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same quarter last year, the firm earned $1.73 EPS. The company’s revenue was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, research analysts predict that Plexus Corp. will post 5.9 earnings per share for the current year.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.